Concepedia

Michael Wiedmann

MW

Statistics

Publications

6

Citations

361

H-Index

6

Active since

2007

Affiliations

Roche Pharma AG (Germany)(Current)

Roche (Switzerland)

Michael Wiedmann is an author at Roche Pharma AG (Germany) specializing in life sciences, biochemistry, and proteomics.

Publications per year

2007–2023

6

Publications

6

Assessment of chemical modifications of sites in the CDRs of recombinant antibodies

Markus Haberger, Katrin Bomans, Katharina Diepold et al. · mAbs · 2014 · 162 citations · Full text

, , +17

Simultaneous Assessment of Asp Isomerization and Asn Deamidation in Recombinant Antibodies by LC-MS following Incubation at Elevated Temperatures

Katharina Diepold, Katrin Bomans, Michael Wiedmann et al. · PLoS ONE · 2012 · 113 citations · Full text

, , +17

Identification and Monitoring of Host Cell Proteins by Mass Spectrometry Combined with High Performance Immunochemistry Testing

Katrin Bomans, Antje Lang, Veronika Roedl et al. · PLoS ONE · 2013 · 37 citations · Full text

, , +17

HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas® TaqScreen MPX test in seroconverting donors

Michael Wiedmann, Sabine Kluwick, Martina Walter et al. · Journal of Clinical Virology · 2007 · 22 citations

, , +8

A fast and sensitive high-throughput assay to assess polysorbate-degrading hydrolytic activity in biopharmaceuticals

Sanjay K. Gupta, Tobias Graf, F.T. Edelmann et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2023 · 14 citations · Full text

, , +17

1–5 of 6